Roy M S, Podgor M J, Bungay P, Grunberger G, Carl J, Ellis D
Clinical Branch, National Eye Institute, Bethesda, MD 20892.
Retina. 1987 Fall;7(3):170-6. doi: 10.1097/00006982-198700730-00006.
Vitreous fluorophotometry (VFP) using the Fluorotron Master was performed in 25 insulin-dependent diabetic patients with either minimal or no retinopathy and 22 controls. At 30 minutes, baseline corrected vitreous fluorescence values 3 mm from the retina were significantly greater in diabetic patients with minimal retinopathy than in either controls or patients with no retinopathy but were similar in patients with no retinopathy and controls. At 1 hour, vitreous fluorescence values and fluorescein permeability indexes were similar in all three groups. The absence of increased posterior vitreous fluorescein leakage in the diabetic patients with no retinopathy suggests that the alteration in permeability of the blood retinal barrier, as assessed by current VFP measures, does not precede the development of clinical diabetic retinopathy. However, the significantly increased 30-minute 3-mm fluorescence values suggest that posterior fluorescein leakage is increased in minimal background diabetic retinopathy.
使用Fluorotron Master进行玻璃体荧光光度测定(VFP),对25例患有轻度或无视网膜病变的胰岛素依赖型糖尿病患者和22例对照者进行了检测。30分钟时,距视网膜3毫米处的基线校正玻璃体荧光值在轻度视网膜病变的糖尿病患者中显著高于对照组或无视网膜病变的患者,但无视网膜病变的患者和对照组相似。1小时时,三组的玻璃体荧光值和荧光素通透性指数相似。无视网膜病变的糖尿病患者玻璃体后荧光素渗漏未增加,这表明通过当前VFP测量评估的血视网膜屏障通透性改变在临床糖尿病视网膜病变发生之前并未出现。然而,30分钟时3毫米处荧光值显著增加表明,轻度背景性糖尿病视网膜病变中玻璃体后荧光素渗漏增加。